Login / Signup

Revisiting the benefits of isovolemic hemodilution red cell exchange for sickle cell disease.

Manasa S ReddyAhmad M AlkashashAndrew NordAnne Tetrick
Published in: Journal of clinical apheresis (2023)
Our data do not support the observation of both IHD-RCE benefits, decreased red cell usage per exchange and lower FCR/increased interprocedure interval, simultaneously.
Keyphrases
  • sickle cell disease
  • single cell
  • cell therapy
  • deep learning
  • stem cells
  • mesenchymal stem cells
  • electronic health record
  • bone marrow
  • data analysis